TY  - CHAP
M1  - Book, Section
TI  - Obstructive and Nonobstructive Coronary Disease in Heart Failure
A1  - Lee, Charlotte
A1  - Dec,  G. William
A2  - Fuster, Valentin
A2  - Narula, Jagat
A2  - Vaishnava, Prashant
A2  - Leon, Martin B.
A2  - Callans, David J.
A2  - Rumsfeld, John S.
A2  - Poppas, Athena
PY  - 2022
T2  - Fuster and Hurst's The Heart, 15e
AB  - Content  UpdateStudy  Summary:  REVIVED-BCIS2The  Revascularization  for  Ischemic  Ventricular  Dysfunction  (REVIVED-BCIS2)  trial  was  a  prospective,  multicenter,  open-label  trial  that  randomized  700  patients  with  left  ventricular  dysfunction  (defined  as  left  ventricular  ejection  fraction  (LVEF)  of  ≤35%),  extensive  coronary  artery  disease  amenable  to  percutaneous  coronary  intervention  (PCI),  and  demonstrable  myocardial  viability  to  a  strategy  of  optimal  medical  therapy  (OMT)  plus  PCI  (n=347)  or  OMT  alone  (n  =  353).  Read  More  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/17
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1202454909
ER  -